Association and predictive value of SII, SIRI and CD4/CD8 ratio with acute onset of bronchial asthma

Background: To analyze the correlation between Systemic immunoinflammatory index (SII), Systemic inflammatory response index (SIRI), Cluster of Differentiation 4+ T cells to Cluster of Differentiation 8+ T cells (CD4+/CD8+) ratio and children with acute attack of bronchial asthma, as well as the prognostic value. Methods: A total of 98 children with bronchial asthma admitted to our hospital from January 2020 to February 2024 were retrospectively collected. Another 50 healthy children who underwent physical examination in our hospital during the same period were selected as the control group. General data of all subjects were collected. SII, SIRI and CD4+/CD8+ ratio were collected and calculated. All the bronchial asthma children were treated with aerosol inhalation of glucocorticoids after admission. After 28 days of treatment, the patients were divided into well-controlled group and poor-controlled group. Among all the 98 patients, 65 patients were well prognosis and 32 patients were poor prognosis. Results: SII and SIRI in the disease group were significantly higher than those in the control group (p < 0.05), and CD4+/CD8+ was significantly lower p than that in the control group (p < 0.05). SII and SIRI in the poor prognosis group were significantly higher than those in the good prognosis group (p < 0.05), and CD4+/CD8+ was significantly lower than those in the good prognosis group (p < 0.05). Conclusions: SII, SIRI and CD4+/CD8+ are closely related to children with acute attack of bronchial asthma. These indicators deserve further attention in clinical practice.

SII; SIRI; CD4/CD8 ratio; Bronchial asthma

[1] Shipp CL, Gergen PJ, Gern JE, Matsui EC, Guilbert TW. Asthma management in children. The Journal of Allergy and Clinical Immunology. 2023; 11: 9–18.

[2] Matsumura Y. Inadequate therapeutic responses to glucocorticoid treatment in bronchial asthma. Journal of International Medical Research. 2023; 51: 3000605231175746.

[3] Wang J, Zhang X, Zhang L, Liu Y, Wang G, Zhang HP, et al. Age-related clinical characteristics, inflammatory features, phenotypes, and treatment response in asthma. The Journal of Allergy and Clinical Immunology. 2023; 11: 210–219.e213.

[4] Xia Y, Xia C, Wu L, Li Z, Li H, Zhang J. Systemic immune inflammation index (SII), system inflammation response index (SIRI) and risk of all-cause mortality and cardiovascular mortality: a 20-year follow-up cohort study of 42,875 US adults. Journal of Clinical Medicine. 2023; 12: 1128.

[5] Dziedzic EA, Gąsior JS, Tuzimek A, Paleczny J, Junka A, Dąbrowski M, et al. Investigation of the associations of novel inflammatory biomarkers-systemic inflammatory index (SII) and systemic inflammatory response index (SIRI)-with the severity of coronary artery disease and acute coronary syndrome occurrence. International Journal of Molecular Sciences. 2022; 23: 9553.

[6] Palomero J, Panisello C, Lozano-Rabella M, Tirtakasuma R, Díaz-Gómez J, Grases D, et al. Biomarkers of tumor-reactive CD4+ and CD8+ TILs associate with improved prognosis in endometrial cancer. The Journal for ImmunoTherapy of Cancer. 2022; 10: e005443.

[7] Bai Y, Zhou Q, Fang Q, Song L, Chen K. Inflammatory cytokines and T-lymphocyte subsets in serum and sputum in patients with bronchial asthma and chronic obstructive pulmonary disease. Medical Science Monitor. 2019; 25: 2206–2210.

[8] Levy ML, Bacharier LB, Bateman E, Boulet LP, Brightling C, Buhl R, et al. Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update. NPJ Primary Care Respiratory Medicine. 2023; 33: 7.

[9] Nelsen LM, Kosinski M, Rizio AA, Jacques L, Schatz M, Stanford RH, et al. A structured review evaluating content validity of the asthma control test, and its consistency with U.S. guidelines and patient expectations for asthma control. Journal of Asthma. 2022; 59: 628–637.

[10] Miller RL, Grayson MH, Strothman K. Advances in asthma: new understandings of asthma’s natural history, risk factors, underlying mechanisms, and clinical management. Journal of Allergy and Clinical Immunology. 2021; 148: 1430–1441.

[11] Kaminsky DA, He J, Henderson R, Dixon AE, Irvin CG, Mastronarde J, et al. Bronchodilator response does not associate with asthma control or symptom burden among patients with poorly controlled asthma. Respiratory Medicine. 2023; 218: 107375.

[12] Bush A. Severe and difficult asthma: diagnosis and management-challenges for a low-resource environment. Indian Journal of Pediatrics. 2022; 89: 156–162.

[13] Dalkılınç Hökenek U, Kılıç M, Alışkan H. Investigation of the prognostic role of systemic immunoinflammatory index in patients with acute pancreatitis. National Journal of Trauma and Emergency Surgery. 2023; 29: 316–320.

[14] Cui S, Cao S, Chen Q, He Q, Lang R. Preoperative systemic inflammatory response index predicts the prognosis of patients with hepatocellular carcinoma after liver transplantation. Frontiers in Immunology. 2023; 14: 1118053.

[15] Kunc P, Fabry J, Lucanska M, Pecova R. Biomarkers of bronchial asthma. Physiological Research. 2020; 69: S29–S34.

[16] Wang B, Hu S, Fu X, Li L. CD4+ cytotoxic T lymphocytes in cancer immunity and immunotherapy. Advanced Biology. 2023; 7: e2200169.

[17] Reina-Campos M, Scharping NE, Goldrath AW. CD8+ T cell metabolism in infection and cancer. Nature Reviews Immunology. 2021; 21: 718–738.

[18] Jin L, Gong H, Zhang Q. The clinical differences between cough variant asthma cells and humoral immunology indicators. Cellular and Molecular Biology. 2022; 68: 188–193.